- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.11.23 | Evommune, Accutar to discover drug candidates for chronic inflammatory diseases | ||
| 28.11.23 | Sernova secures ODD and RPDD for Haemophilia A programme | ||
| 27.11.23 | Mesoblast files applications with US FDA for HLHS therapy | ||
| 24.11.23 | Boehringer Ingelheim announces acquisition of T3 Pharmaceuticals | ||
| 23.11.23 | US FDA approves Valneva's vaccine against chikungunya virus | ||
| 22.11.23 | BeiGene to acquire global license to Ensem Therapeutics' CDK2 inhibitor | ||
| 21.11.23 | NeoImmuneTech receives orphan drug status for NT-I7 to treat ARS | ||
| 20.11.23 | Almirall obtains approval from EC for atopic dermatitis therapyx | ||
| 17.11.23 | Q32 Bio to merge with Homology Medicines | ||
| 16.11.23 | Xentria receives ODD from EMA for anti-TNFa monoclonal antibody | ||
| 15.11.23 | Kesin Pharma receives approval from FDA for LIKMEZ | ||
| 14.11.23 | Otsuka Pharmaceutical submits NDA for voclosporin in Japan | ||
| 13.11.23 | Lipella Pharmaceuticals gets ODD for LP-310 to treat GvHD | ||
| 10.11.23 | Valneva Austria receives FDA approval for chikungunya vaccine | ||
| 09.11.23 | Juventas receives NMPA market approval for cell therapy | ||
| 08.11.23 | OrsoBio raises $60m to advance treatment for obesity and associated disorders | ||
| 07.11.23 | Halozyme, Acumen partner for ENHANZE drug delivery technology | ||
| 06.11.23 | Mirati receives approval from UK's MHRA for NSCLC therapy | ||
| 03.11.23 | Noramco buys Drug Product Business Unit from Cambrex | ||
| 02.11.23 | Prelude announces partnership with AbCellera for oncology ADCs | ||
| 01.11.23 | Altasciences concludes US laboratory facility expansion | ||
| 31.10.23 | Basilea, iNtRON sign deal for antibacterial agent | ||
| 30.10.23 | Canada's PharmaDrug signs agreement to acquire Securedose Synthetics | ||
| 27.10.23 | ThermoGenesis opens cell and gene therapy facility in Sacramento, US | ||
| 26.10.23 | Mithra signs license agreement with Searchlight for Donesta in Canada |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
